Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Merck Kgaa ADR (MKKGY)

Merck Kgaa ADR (MKKGY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.7100 +5.31%
on 09/17/19
23.2099 -1.50%
on 09/20/19
+1.0595 (+4.86%)
since 09/13/19
3-Month
20.2200 +13.07%
on 07/31/19
23.2099 -1.50%
on 09/20/19
+2.0440 (+9.82%)
since 07/12/19
52-Week
19.2000 +19.07%
on 05/31/19
23.2099 -1.50%
on 09/20/19
+2.8320 (+14.14%)
since 10/12/18

Most Recent Stories

More News
EMD Serono Announces JAMA Publication of Phase II Results of Sprifermin for Osteoarthritis Structure Modification

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that results from FORWARD, a five-year, multicenter Phase II study of sprifermin, a...

MKKGY : 22.8620 (+0.14%)
Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors

Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that it has achieved a milestone under its collaboration and license agreement with the healthcare division of Merck KGaA, Darmstadt, Germany and is...

MKKGY : 22.8620 (+0.14%)
STRO : 9.34 (-1.48%)
Merck KGaA, Darmstadt, Germany, Completes Acquisition of Versum Materials

Versum Materials, Inc., a leading materials supplier to the semiconductor industry, today announced that it has completed the announced transaction with Merck KGaA, Darmstadt, Germany.

MKKGY : 22.8620 (+0.14%)
VSM : 52.99 (+0.02%)
APD : 213.86 (-1.58%)
Benefitting From Expanded Access in Europe, Roche's Ocrevus is on Track to Displace Biogen's Tysabri in Neurologist Preference and Share Among Patients with Relapsing Forms of Multiple Sclerosis Over the Next Six Months

Expanded access to Merck KGaA's Mavenclad and Roche's Ocrevus in Europe has significantly shifted neurologists' reported disease-modifying therapy (DMT) treatment patterns among multiple sclerosis (MS)...

MKKGY : 22.8620 (+0.14%)
NVS : 85.93 (-0.77%)
Mercury Systems Set to Join S&P MidCap 400; Cleveland-Cliffs and Essential Properties Realty Trust to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:

MKKGY : 22.8620 (+0.14%)
MRCY : 75.01 (-0.77%)
VSM : 52.99 (+0.02%)
CLF : 7.17 (-5.91%)
EPRT : 23.72 (-0.29%)
NCI : 27.99 (unch)
SPGI : 251.37 (-0.64%)
Versum Materials Announces China Antitrust Clearance of Merger with Merck KGaA, Darmstadt, Germany; Announces Expected Closing Date

Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, today announced that the State Administration for Market Regulation of the People's Republic of China (SAMR)...

MKKGY : 22.8620 (+0.14%)
VSM : 52.99 (+0.02%)
APD : 213.86 (-1.58%)
New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care

Not intended for UK-based media

MKKGY : 22.8620 (+0.14%)
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP)...

MKKGY : 22.8620 (+0.14%)
PFE : 36.30 (+0.53%)
Versum Materials Announces CFIUS Clearance of Merger with Merck KGaA, Darmstadt, Germany

Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, today announced that Versum has received notice from the Committee on Foreign Investment in the United States...

MKKGY : 22.8620 (+0.14%)
VSM : 52.99 (+0.02%)
APD : 213.86 (-1.58%)
Merck KGaA, Darmstadt, Germany, Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations

Not intended for UK-based media

MKKGY : 22.8620 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MKKGY with:

Key Turning Points

2nd Resistance Point 22.9567
1st Resistance Point 22.9093
Last Price 22.8620
1st Support Level 22.8303
2nd Support Level 22.7987

See More

52-Week High 23.2099
Last Price 22.8620
Fibonacci 61.8% 21.6781
Fibonacci 50% 21.2050
Fibonacci 38.2% 20.7318
52-Week Low 19.2000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar